Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.

Detalles Bibliográficos
Autores principales: Ortolano, Rita, Baronio, Federico, Masetti, Riccardo, Prete, Arcangelo, Cassio, Alessandra, Pession, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344415/
https://www.ncbi.nlm.nih.gov/pubmed/28316933
http://dx.doi.org/10.1016/j.ymgmr.2017.02.003
_version_ 1782513537907687424
author Ortolano, Rita
Baronio, Federico
Masetti, Riccardo
Prete, Arcangelo
Cassio, Alessandra
Pession, Andrea
author_facet Ortolano, Rita
Baronio, Federico
Masetti, Riccardo
Prete, Arcangelo
Cassio, Alessandra
Pession, Andrea
author_sort Ortolano, Rita
collection PubMed
description
format Online
Article
Text
id pubmed-5344415
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53444152017-03-17 Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al. Ortolano, Rita Baronio, Federico Masetti, Riccardo Prete, Arcangelo Cassio, Alessandra Pession, Andrea Mol Genet Metab Rep Correspondence Elsevier 2017-03-07 /pmc/articles/PMC5344415/ /pubmed/28316933 http://dx.doi.org/10.1016/j.ymgmr.2017.02.003 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Ortolano, Rita
Baronio, Federico
Masetti, Riccardo
Prete, Arcangelo
Cassio, Alessandra
Pession, Andrea
Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.
title Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.
title_full Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.
title_fullStr Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.
title_full_unstemmed Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.
title_short Letter to the Editors: Concerning “Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state” by Takashi M et al.
title_sort letter to the editors: concerning “divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset pompe disease treated in the symptomatic or pre-symptomatic state” by takashi m et al.
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344415/
https://www.ncbi.nlm.nih.gov/pubmed/28316933
http://dx.doi.org/10.1016/j.ymgmr.2017.02.003
work_keys_str_mv AT ortolanorita lettertotheeditorsconcerningdivergentclinicaloutcomesofalphaglucosidaseenzymereplacementtherapyintwosiblingswithinfantileonsetpompediseasetreatedinthesymptomaticorpresymptomaticstatebytakashimetal
AT baroniofederico lettertotheeditorsconcerningdivergentclinicaloutcomesofalphaglucosidaseenzymereplacementtherapyintwosiblingswithinfantileonsetpompediseasetreatedinthesymptomaticorpresymptomaticstatebytakashimetal
AT masettiriccardo lettertotheeditorsconcerningdivergentclinicaloutcomesofalphaglucosidaseenzymereplacementtherapyintwosiblingswithinfantileonsetpompediseasetreatedinthesymptomaticorpresymptomaticstatebytakashimetal
AT pretearcangelo lettertotheeditorsconcerningdivergentclinicaloutcomesofalphaglucosidaseenzymereplacementtherapyintwosiblingswithinfantileonsetpompediseasetreatedinthesymptomaticorpresymptomaticstatebytakashimetal
AT cassioalessandra lettertotheeditorsconcerningdivergentclinicaloutcomesofalphaglucosidaseenzymereplacementtherapyintwosiblingswithinfantileonsetpompediseasetreatedinthesymptomaticorpresymptomaticstatebytakashimetal
AT pessionandrea lettertotheeditorsconcerningdivergentclinicaloutcomesofalphaglucosidaseenzymereplacementtherapyintwosiblingswithinfantileonsetpompediseasetreatedinthesymptomaticorpresymptomaticstatebytakashimetal

Ejemplares similares